Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e11c6c1cd9e69dd65b75c7f4dec0ce6a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-115 |
filingDate |
2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_257b88ff9bb8c6f8e249c70136f2e61a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b5ae43ec1175f542238c469112132dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3efeda697c50d39003277069019d8400 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c888e83106e0d0ad8ec9684a51e4b127 |
publicationDate |
2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-110996998-A |
titleOfInvention |
Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and uses thereof |
abstract |
Provided are recombinant chimeric bovine/human parainfluenza virus 3 (rB/HPIV3) vectors expressing respiratory syncytial virus (RSV) G protein or recombinant RSV G protein, and methods of using and making them. The rB/HPIV3 vector comprises a genome comprising a heterologous gene encoding the RSV G protein or the recombinant RSV G protein. Nucleic acid molecules comprising sequences of the genome or antigenome of the disclosed rB/HPIV3 vectors are also provided. The disclosed rB/HPIV3 vectors can be used, for example, to induce an immune response to RSV and HPIV3 in a subject. |
priorityDate |
2017-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |